after curative resection of colorectal cancer
Conditions
Interventions
Trial group:Traditional Chinese medicine
Control:Traditional Chinese medicine
Sponsors
Putuo Hospital, Shanghai University of Traditional Chinese Medicine
Eligibility
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. volunteered to participate in this study and signed an informed consent form; 2.there is a clear pathological diagnosis of colorectal cancer patients after radical surgery; 3.TMN staging Phase II or III; 4.do standard adjuvant chemotherapy, expected survival more than 3 months; 5. TCM reference to Chinese medicine clinical research guidelines (third series) developed by the People's Republic of China Ministry of Health; 6. no serious disorders in heart, liver, kidney, and hematopoietic system, chemotherapy contraindications, and other drug evaluation factors; 7 .Age from 18 to 75 years old, no sex limit; 8 .Karnofsky score more than 70 points.
Exclusion criteria
Exclusion criteria: 1.do not meet the inclusion criteria above; 2.the patients with abdominal or hepatic recurrence or metastasis; 3.significant heart (history of severe heart disease, such as coronary heart disease,myocardial infarction and so on), liver (ALT, AST has obvious abnormalities), kidney (CKD stage> 2) or other function damage, mentally ill, pregnant or lactating women; 4. allergies or multiple drug allergies; 5. patients participated in other clinical trials, before the trial three months ago.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VEGF;Immune functionCD3, CD4;Tumor markers CA199, CE; | — |
Secondary
| Measure | Time frame |
|---|---|
| Piper Fatigue Scale;TCM Syndrome Rating Scal; | — |
Countries
China
Contacts
Public ContactYIN PEIHAO
Outcome results
None listed